The growing human population has driven the demand for animal products such as milk, chicken, eggs, and meat. Vaccines help minimize animal loss and ensure their safety, which is likely to drive market growth over the forecast period. The increasing production and consumption of milk and milk products in countries such as India are further expected to contribute to market growth.
In developing countries, livestock is a contributor to GDP; hence, there is increasing demand for efficient animal healthcare practices, which is expected to drive growth in this market over the forecast period. For instance, in July 2024, according to information published by the Ministry of Finance (India), 4.6% of total GVA in 2022-23 was contributed by the livestock sector, thereby boosting the per capita availability of milk, eggs, and meat. The livestock population has increased rapidly owing to the adoption of advanced medication and vaccination programs to maintain livestock health.
Various government initiatives and programs have boosted growth in this market. According to the Food and Agriculture Organization of the U.S. and the World Organization for Animal Health, SEACFMD 2021-2025 was launched to increase productivity and economic output in the livestock sector by managing and eradicating FMD, thereby enhancing food security and supporting rural smallholder farmers. Investments made by government institutions have supported the production of FMD vaccines and boosted the market growth.
Global Foot And Mouth Disease Vaccine Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, the analyst has segmented the global foot and mouth disease vaccine market report based on animal, vaccine, distribution channel, and region:Animal Outlook (Revenue, USD Billion, 2021 - 2033)
- Cattle
- Sheep and Goat
- Swine
- Others
Vaccine Outlook (Revenue, USD Billion, 2021 - 2033)
- Modified/ Attenuated Live
- Inactivated (Killed)
- Other Vaccines
Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
- Veterinary Hospitals & Clinics
- Government Institutions
- Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- Europe
▪ France
- Asia Pacific
▪ China
▪ India
▪ South Korea
▪ Indonesia
▪ Thailand
- Latin America
▪ Argentina
- MEA
▪ Saudi Arabia
▪ UAE
▪ Kuwait
▪ Egypt
▪ Turkey
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Biogénesis Bagó
- Zoetis Services LLC
- Boehringer Ingelheim International GmbH
- Bayer AG
- HESTER BIOSCIENCES LIMITED
- Botswana Vaccine Institute
- China Animal Husbandry Industry Co. Ltd.
- MEVAC
- Ourofino

